Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors
Clinical trial NCT02156388 · COMPLETED
Trial details
- NCT number
- NCT02156388
- Sponsor
- Jiangsu T-Mab Biopharma Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2015-02-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.